Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Reexamination Certificate
2009-04-20
2011-12-27
Hanley, Susan (Department: 1653)
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
C424S094630, C424S094610, C435S195000, C435S198000, C435S201000, C435S202000, C435S212000, C435S213000, C435S219000
Reexamination Certificate
active
08084025
ABSTRACT:
A therapeutic agent for the treatment of the symptoms of addiction and the method for preparing the therapeutic agent is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using of a biomarker, the presence of chymotrypsin in the gastrointestinal tract to determine the presence of symptoms of addiction, and the likelihood of relapsing into addiction is disclosed.
REFERENCES:
patent: 3002883 (1961-10-01), Butt et al.
patent: 3223594 (1965-12-01), Serge
patent: 3357894 (1967-12-01), Jose et al.
patent: 3515642 (1970-06-01), Mima et al.
patent: 3574819 (1971-04-01), Gross et al.
patent: 3940478 (1976-02-01), Kurtz
patent: 4079125 (1978-03-01), Sipos
patent: 4145410 (1979-03-01), Sears
patent: 4241046 (1980-12-01), Papahadjopoulos et al.
patent: 4826679 (1989-05-01), Roy
patent: 5190775 (1993-03-01), Klose
patent: 5250418 (1993-10-01), Moller et al.
patent: 5324514 (1994-06-01), Sipos
patent: 5436319 (1995-07-01), Kung et al.
patent: 5437319 (1995-08-01), Garuglieri
patent: 5439935 (1995-08-01), Rawlings et al.
patent: 5460812 (1995-10-01), Sipos
patent: 5476661 (1995-12-01), Pillai et al.
patent: 5527678 (1996-06-01), Blaser et al.
patent: 5585115 (1996-12-01), Sherwood et al.
patent: 5607863 (1997-03-01), Chandler
patent: 5648335 (1997-07-01), Lewis et al.
patent: 5674532 (1997-10-01), Atzl et al.
patent: 5686311 (1997-11-01), Shaw
patent: 5750104 (1998-05-01), Sipos
patent: 5776917 (1998-07-01), Blank et al.
patent: 5858758 (1999-01-01), Hillman et al.
patent: 5952178 (1999-09-01), Lapidus et al.
patent: 5958875 (1999-09-01), Longo et al.
patent: 5985891 (1999-11-01), Rowe
patent: 6011001 (2000-01-01), Navia et al.
patent: 6013286 (2000-01-01), Klose
patent: 6020310 (2000-02-01), Beck et al.
patent: 6020314 (2000-02-01), McMichael
patent: 6153236 (2000-11-01), Wu et al.
patent: 6187309 (2001-02-01), McMichael et al.
patent: 6197746 (2001-03-01), Beck et al.
patent: 6210950 (2001-04-01), Johnson et al.
patent: 6251478 (2001-06-01), Pacifico et al.
patent: 6261613 (2001-07-01), Narayanaswamy et al.
patent: 6280726 (2001-08-01), Weinrauch et al.
patent: 6309669 (2001-10-01), Setterstrom et al.
patent: 6399101 (2002-06-01), Frontanes et al.
patent: 6482839 (2002-11-01), Thornfeldt
patent: 6534063 (2003-03-01), Fallon
patent: 6534259 (2003-03-01), Wakefield
patent: 6632429 (2003-10-01), Fallon
patent: 6660831 (2003-12-01), Fallon
patent: 6727073 (2004-04-01), Moore et al.
patent: 6743447 (2004-06-01), Labergerie et al.
patent: 6797291 (2004-09-01), Richardson
patent: 6835397 (2004-12-01), Lee et al.
patent: 6852487 (2005-02-01), Barany et al.
patent: 7101573 (2006-09-01), Szymczak et al.
patent: 7129053 (2006-10-01), Reiter et al.
patent: 7138123 (2006-11-01), Fallon
patent: 7232670 (2007-06-01), D'Azzo et al.
patent: 2002/0037284 (2002-03-01), Fallon
patent: 2002/0081628 (2002-06-01), Fallon
patent: 2002/0090653 (2002-07-01), Fallon
patent: 2003/0097122 (2003-05-01), Ganz et al.
patent: 2004/0057944 (2004-03-01), Galle et al.
patent: 2004/0057962 (2004-03-01), Timmerman
patent: 2004/0071683 (2004-04-01), Fallon
patent: 2004/0076590 (2004-04-01), Wilkins
patent: 2004/0101562 (2004-05-01), Maio
patent: 2004/0121002 (2004-06-01), Lee et al.
patent: 2004/0209790 (2004-10-01), Sava et al.
patent: 2005/0187130 (2005-08-01), Booker et al.
patent: 2006/0105379 (2006-05-01), Wu et al.
patent: 2006/0182728 (2006-08-01), Fallon
patent: 2006/0183180 (2006-08-01), Fallon
patent: 2006/0198838 (2006-09-01), Fallon
patent: 2006/0258599 (2006-11-01), Childers
patent: 2006/0259995 (2006-11-01), Cayouette et al.
patent: 2007/0053895 (2007-03-01), Fallon
patent: 2007/0116695 (2007-05-01), Fallon
patent: 2008/0058282 (2008-03-01), Fallon
patent: 2008/0152637 (2008-06-01), Fallon
patent: 2008/0161265 (2008-07-01), Fallon et al.
patent: 2008/0166334 (2008-07-01), Fallon
patent: 2008/0219966 (2008-09-01), Fallon
patent: 2008/0254009 (2008-10-01), Finegold
patent: 2008/0279839 (2008-11-01), Schuler et al.
patent: 2008/0317731 (2008-12-01), Gramatikova et al.
patent: 2009/0130081 (2009-05-01), Fallon
patent: 2009/0197289 (2009-08-01), Fallon
patent: 2009/0232789 (2009-09-01), Fallon
patent: 2009/0285790 (2009-11-01), Fallon
patent: 2009/0286270 (2009-11-01), Fallon
patent: 2009/0324572 (2009-12-01), Fallon
patent: 2009/0324730 (2009-12-01), Fallon
patent: 2010/0092447 (2010-04-01), Fallon
patent: 2010/0169409 (2010-07-01), Fallon et al.
patent: 2010/0233218 (2010-09-01), Fallon
patent: 2010/0260857 (2010-10-01), Fallon et al.
patent: 2011/0182818 (2011-07-01), Fallon
patent: 4332985 (1995-03-01), None
patent: 0451484 (1991-10-01), None
patent: 0564739 (1993-10-01), None
patent: 0564739 (1995-04-01), None
patent: 2347742 (2000-09-01), None
patent: 62230714 (1987-10-01), None
patent: WO 95/22344 (1995-08-01), None
patent: WO 98/22499 (1998-05-01), None
patent: WO 98/22499 (1998-07-01), None
patent: WO 98/52593 (1998-11-01), None
patent: WO 99/64059 (1999-12-01), None
patent: WO 00/09142 (2000-02-01), None
patent: WO 99/64059 (2000-03-01), None
patent: WO 01/27612 (2001-04-01), None
patent: WO 01/43764 (2001-06-01), None
patent: WO 01/27612 (2001-10-01), None
patent: WO 01/43764 (2001-11-01), None
patent: WO 02/14537 (2002-02-01), None
patent: WO 02/14537 (2002-05-01), None
patent: WO 2009/114757 (2009-09-01), None
patent: WO 2010/002972 (2010-01-01), None
patent: WO 2010/080830 (2010-07-01), None
patent: WO 2010/080835 (2010-07-01), None
Derwent abstract for RU 2286785 (Nov. 10, 2006) downloaded from the Derwent file Jul. 13, 2011.
Smith et al. (1971) Canadian Medical Association Journal 104(8): 691-4 and 697.
ABCnews. Changing Face of Autism: Numbers Rise as More Behaviors Included. ABCnews. Nov. 1, 2007.
Aman, et al. Outcome measures for clinical drug trials in autism. CNS Spectr. Jan. 2004;9(1):36-47.
Ang, et al. Biological role and regulation of the universally conserved heat shock proteins. J Biol Chem. Dec. 25, 1991;266(36):24233-6.
APDA. Basic Information About Parkinson's Disease. Jul. 14, 2008.
Arribas, et al. A comparative study of the chymotrypsin-like activity of the rat liver multicatalytic proteinase and the ClpP fromEscherichia coli.J Biol Chem. Oct. 5, 1993;268(28):21165-71, abstract considered.
Arrigo, et al. Expression of heat shock proteins during development inDrosophila. Results Probl Cell Differ. 1991;17:106-19, abstract considered.
Ash. Patient Information Guide—Understanding Hypertension. American Society of Hypertension. 2004. 1-7.
Ashwood, et al. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol. Dec. 19, 2005; 1-9.
Ashwood, et al. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol. Nov. 2003;23(6):504-17.
Ashwood, et al. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol. Nov. 2004;24(6):664-73.
Austic. Development and adaptation of protein digestion. J Nutr. May 1985;115(5):686-97.
Autism Society of America. Incidence Numbers from Other Countries. Jul. 14, 2008.
Awazuhara, et al. Antigenicity of the proteins in soy lecithin and soy oil in soybean allergy. Clin Exp Allergy. Dec. 1998;28(12):1559-64.
Bailey, et al. Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am J Med Genet A. Aug. 15, 2008;146A(16):2060-9.
Bakkaloglu, et al. Atopic features in early childhood autism. Eur J Paediatr Neurol. Nov. 2008;12(6):476-9.
Barnhart, et al. Symptomatic granular cell tumor involving the pituitary gland in a dog: a case report and review of the literature. Vet Pathol. May 2001;38(3):332-6.
Beilmann, et a
Curemark LLC
Hanley Susan
Wilson Sonsini Goodrich & Rosati
LandOfFree
Method for the treatment of the symptoms of drug and alcohol... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of the symptoms of drug and alcohol..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of the symptoms of drug and alcohol... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4313272